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Objectives: Lymph transportation through the body is partly controlled by the intrinsic pumping of lymphatic vessels.
Although an understanding of this process is important for medical application, little is currently known because it is
difficult to measure. Here, we introduce an easy, safe, and cost-effective technique for measuring lymphatic pumping in
leg superficial lymphatic vessels. Readings obtained with this technique were compared with values obtained with
dynamic lymphoscintigraphy. Differences in lymphatic pumping between healthy volunteers and patients with lymphed-
ema were also investigated.
Methods: Indocyanine green (ICG) fluorescence lymphography was performed by subcutaneously injecting 0.3 mL of ICG
(0.5%) into the dorsum of the foot. Real-time fluorescence images of lymph propulsion were obtained with an
infrared-light camera system with the individual supine or sitting. A custom-made transparent sphygmomanometer cuff
was wrapped around the lower leg and connected to a standard mercury sphygmomanometer. The cuff was inflated to 60
mmHg and then gradually deflated at 5-minute intervals to lower the pressure by 10-mmHg steps until the fluorescence
contrast agent exceeded the upper border of the cuff, indicating that the lymphatic contraction had overcome the cuff
pressure. Lymph pumping pressure (Ppump) was defined as the value of the cuff pressure when the contrast agent exceeded
the upper border of the cuff. We measured Ppump among healthy volunteers who maintained a supine position and
compared these values with measurements obtained from lymphoscintigraphy. Ppump values while sitting were also
compared between 30 legs from healthy volunteers and 30 legs from lymphedematous patients.
Results: Among healthy, supine participants, Ppump was 25.2  16.7 mm Hg (mean  standard deviation [SD]) when
measured by ICG fluorescence lymphography. These values were significantly correlated with values taken using dynamic
lymphoscintigraphy (r2  0.54, p < .01), while 2 SDs of the mean were approximately 20 mm Hg, suggesting a
substantial disagreement between the two methods (Bland-Altman plots). In the comparison of seated meaurements,
readings for healthy participants (Ppump 29.3 16.0) were higher than those for lymphedematous participants (13.2
14.9).
Conclusion: ICG fluorescence is an accurate—as well as a safe, easy, and economical—method of measuring lymphatic
pumping. Therefore, it may develop as a vital tool for diagnosing lymphatic malfunctions even when they are only in their
formative stages. Studies that use this technique may increase our knowledge of the lymphatic system as a whole, allowing
us to develop better treatments for lymphatic disorders. ( J Vasc Surg 2010;52:946-52.)The lymphatic transport system is important in a variety
of physiologic processes, including immune reactions, lipid
absorption, and maintenance of body fluid and macromol-
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946ecule balances. One component of this system is lymphat-
ics, the channels responsible for transporting lymph from
the body back to the bloodstream. It has been proposed
that the intrinsic contraction of lymphatics—a process
known as lymphatic pumping—is one of the major mech-
anisms responsible for propelling lymph to the central
lymphatic systems, and decreases in lymphatic pumping
may cause lymph stasis, or lymphedema. Normal lymphatic
functioning is vital for maintaining circulatory and immu-
nologic health.1,2
Since the first observations of contractions in the lym-
phatic vessels, lymphatic pumping has been thought to
propel lymph centripetally. The first observations of this
activity were reported by Kinmonth and Taylor in 1956
after they observed contractions in a human thoracic duct
during surgery.3,4 Several studies over the next decade
reported additional evidence of lymphatic contraction,5,6
but it was not until 1974 that intralymphatic pressure was
measured for the first time in a human leg.7 To do this,
researchers introduced a pressure transducer by cannula
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from 1 to 40 mm Hg. Additional research indicated that
the systolic end pressure in superficial lymphatics, when the
lymph flow was obstructed, was 44.7  18.9 mm Hg if
individuals were standing or 37.9  12.9 mm Hg if su-
pine.8 Other groups using similar methodologies also re-
ported that the peak pressure of leg superficial lymphatics
was about 30 to 40 mm Hg.9,10
Most studies have been performed in healthy volun-
teers. Investigations of lymphatic pressure in patients with
lymphatic diseases have not been performed because direct
measurements are difficult and potentially harmful. There-
fore, research into lymphatic pumping during the last few
decades provided physicians with little knowledge about
how this process is affected by disease or aging. This is
unfortunate, because these data would be invaluable in a
clinical setting. This stagnation of clinical research is pre-
dominantly attributable to the lack of a noninvasive
method of measuring lymphatic pumping.
In 2007, however, Modi et al1 introduced a minimally
invasivemethod of measuring arm lymphatic pressure using
lymphoscintigraphy. This technique was applied to healthy
individuals and those with lymphedema. Researchers used a
standard sphygmomanometer cuff to interrupt lymph flow
by inflating the cuff to 60 mm Hg (cuff pressure ranging
from 60 to 70 mmHg had previously been documented as
sufficient for preventing lymph flow from the wrist to the
axilla).11 Next, cuff pressure was reduced by 10-mm Hg
decrements until it reached 0 mm Hg. The resulting time-
activity curves indicated that lymphatic pressure could be
defined as the value at which the radiotracer passed under
the cuff.
Lymphoscintigraphy is currently considered a major
imaging modality for the diagnosis of patients with lym-
phatic disorders.12,13 However, this technique is time con-
suming, expensive, and potentially teratogenic during
pregnancy, and, therefore, has only been performed on
select patients.14
We recently introduced indocyanine green (ICG) flu-
orescence lymphography as a novel imaging test to visualize
superficial (dermal and subdermal lymphatics) real-time
lymph flow. Furthermore, we reported that this imaging
Fig 1. Measurement of lymphatic pumping in the lowe
nometer cuff with volunteers (A) supine or (B) sitting.technique is useful for assessing lymphatic flow both mor-phologically and functionally.15-17 In this study, we
adapted the ICG fluorescence lymphography technique for
measuring superficial lymphatic pumping in the human leg
and comparing the contractile force between healthy and
lymphedematous legs.
METHODS
This study was approved by the Ethical Committee of
Hamamatsu University School ofMedicine. Informed con-
sent was obtained from all participants.
Measuring lymphatic pumping with ICG fluores-
cence lymphography. Using a 27-gauge needle, we sub-
cutaneously injected 0.3 mL of ICG (Diagnogreen 0.5%;
Daiichi-Sankyo Pharmatical, Tokyo, Japan) at the dorsum
of each participant’s foot. Immediately after the injection,
fluorescence images of subcutaneous lymphatic drainage
were obtained using an infrared camera system (PDE,
Hamamatsu Photonics K.K., Hamamatsu, Japan), which
activates ICG with emitted light at a wavelength of 760 nm
and filters out light with a wavelength820 nm. The light
source for emission of ICG consisted of 760-nm light-
emitting diodes, and the detector was a charge-coupled
device (CCD) camera. The fluorescence images were con-
tinuously observed on the monitor of a laptop computer
(LaVie G, Type T; NEC Co, Tokyo, Japan).
Before the ICG was injected, a custom-made transpar-
ent sphygmomanometer cuff was wrapped around the
lower leg just below the popliteal fossa (Fig 1) and con-
nected to a standard mercury sphygmomanometer.18 Mea-
surements of lymphatic pumping were performed with the
individual supine or sitting. Immediately after the subcuta-
neous injection of ICG, the transparent cuff was inflated to
60 mm Hg, and then gradually deflated to lower the
pressure by 10-mm Hg steps every 5 minutes. This pro-
ceeded until the fluorescence contrast agent exceeded the
upper border of the cuff, indicating that lymphatic contrac-
tion had overcome the cuff pressure. The value of the cuff
pressure at this point was used as a measure of lymph
pumping pressure (Ppump; Fig 2).
ICG fluorescence lymphography and dynamic lym-
phoscintigraphy measurement of lymphatic pumping
in patients without lymphedema. Between December
wrapped with a custom-made transparent sphygmoma-r leg11, 2008, and September 18, 2009, we measured lym-
eviati
ter cu
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lymphedema. Patients were a mean age of 71.9  12.1
years and were hospitalized in our surgical ward for treat-
ment of abdominal aortic aneurysms (AAA) and agreed to
participate in this study (Table). All study participants were
screened for venous insufficiency and deep venous throm-
bosis by duplex scanning and underwent both ICG fluores-
cence lymphography and lymphoscintigraphy before AAA
Fig 2. Indocyanine green fluorescence lymphography: (
border of the cuff; (B) lymph propulsion moving across t
the midpoint of the cuff; and (D) lymph propulsion movi
most advanced indocyanine green contrast agent in the ly
outlines the lower leg.











Age, mean  SD, y 71.9  12.1
AAA, Abdominal aortic aneurysm; ICG, indocyanine green; SD, standard d
Fig 3. Measuring lymphatic pumping with lymphoscint
ual supine under the gamma camera. Sphygmomanomesurgery.We collected two pressure readings from both legs of
the 27 individuals while they were supine (Fig 1, A). The
first measurement was taken using ICG fluorescence lym-
phography; within a couple of days, a second measurement
was taken using dynamic lymphoscintigraphy (Fig 3). With
this technique, 0.3 mL of technetium 99m-labeled human
serum albumin diethylenetriamine pentaacetic acid (activ-
ity 111 MBq; Nihon Medi-Physics Co. Ltd., Nishinomiya,
al-time images of stagnant lymph propulsion at the lower
wer border of the cuff; (C) lymph propulsion moving to
ross the upper border of the cuff. The arrows indicate the
vessel, the solid line outlines the cuff, and the dotted line
Secondary lymphedema patients Healthy volunteers
23 15
30 30




61.8  11.7 58.5  13.5
on.
hy. Lymphatic pumping was measured with the individ-




cintigigrapJapan) was injected subcutaneously at the dorsum of the
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injected. Because of the gamma camera limitations, dy-
namic lymphoscintigraphy can only be performed while
patients are supine; thus, all individuals remained supine
while their legs were imaged. A gamma camera, the Dual-
Head Variable-Geometry Nuclear Imaging System (Mille-
niumVG, GEHeatlhcare, Chalfont St. Giles, United King-
dom) was used to obtain images of the lower leg, including
the cuff region, every 30 seconds for a period of 40minutes.
These images were used to create time–activity curves of
the upper border of the cuff (Fig 4). Lymphatic pumping
was measured using the same techniques used for the ICG
fluorescence lymphography measurement. Lymphatic
pumping pressure was measured as the point at which the
lymphatic contraction overcame the cuff pressure, when the
counts at the upper border of the cuff steadily rose.
ICG fluorescence lymphography measurement of
lymphatic pumping in healthy volunteers and patients
with secondary lymphedema. We also wished to com-
pare lymphatic pressure readings in healthy and lymphed-
ematous patients. In both groups, lymphatic pumping of
the lower legs was measured while participants remained
sitting (Fig 1, B) To this end, we examined both legs of 15
healthy female volunteers (mean age, 61.8  11.7 years)
and 23 female patients with secondary lymphedema (mean
age, 58.5  13.5 years) who came to our vascular surgery
Fig 4. Typical case of a dynamic lymphoscintigraph of
of the cuff where the time-activity curves were created. A
the time-activity curve at the upper border of the cuff sh
indicating that the lymph pumping pressure is 20 to 29
through f in the graph.outpatients clinic between February 7, 2008, and Septem-ber 11, 2009 (Table). Lymphedema patients with active
bacterial cellulitis were excluded. None of the healthy vol-
unteers had a history of leg edema. Duplex scanning was
performed to exclude individuals with deep venous throm-
bosis or chronic venous insufficiency.
Of the patients with secondary lymphedema, 16 had
unilateral leg lymphedema and 7 had bilateral leg lymphed-
ema; all diagnoses were based on lymphoscintigrams per-
formed at our outpatient clinic. All 23 secondary lymphed-
ema patients only underwent compression therapy after
manifestation of leg swelling. Five of the 23 patients were
diagnosed with stage I lymphedema (mild, easily reversible
edema unaccompanied by skin change, sepsis, and limita-
tion of daily activity, and permitting good quality of life
with minimal limitations on exercise), and 18 were diag-
nosed with stage II (moderate edema that is reversible by
massage and compression, accompanied by minimal skin
change without dermatofibrosclerosis and by occasional
sepsis, permitting daily activity with occasional limitations,
and allowing fair quality of life with moderate physical
limitations).19 Of the patients with secondary lymphed-
ema, 20 had uterine cancer, 2 had ovarian cancer, and 1 had
myoma uteri. Hysterectomy was performed with extended
lymph node dissection and local radiation therapy in 13
patients, with lymph node dissection without radiation was
in 7, and with no accompanying procedure in 3. There was
wer leg. The circles indicate the site at the upper border
23 min, with pressure of the cuff (Pcuff) at 20 mm Hg,
an elevation in number of counts per minute (arrow d),
Hg. Panels a through f (top) correspond with arrows athe lo
t t 
ows
mmno difference in lymphatic pumping among the lymphed-
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(plus hysterectomy) with radiation, lymph node excision
without radiation, or no accompanying procedure (data
not shown). All measurements were collected at about
noon, before lunch.
Statistical analysis. All data are expressed as mean 
SD, and differences in the means of the two comparison
groups were assessed using paired t tests. Prism 5 software
(GraphPad Software, San Diego, Calif) was used to con-
duct all statistical analyses, including regressions and corre-
lations. Medicalc 11.2 software (Medcalc Software, Mari-
akerke, Belgium) was used to perform Bland-Altman
analysis to further evaluate the agreement between lym-
phatic pumping data obtained by ICG fluorescence lym-
phography and dynamic lymphoscintigraphy. Significance
was defined as P  .05.
RESULTS
Comparison of lymphatic pumping measurements
taken using two different imaging methods. Both mea-
surements were performed while individuals were supine.
In the ICG fluorescence lymphography method, real-time
images of superficial lymph vessels showed interruption of
ICG movement at the lower border of the cuff at 60 mm
Hg. Stepwise reduction of cuff pressure restarted the lymph
propulsion, and the contrast agent was seen to move across
the upper border of the cuff when the lymphatic pumping
pressure overcame cuff pressure. This point, Ppump, was
measured as 25.2  16.7 mm Hg by ICG fluorescence
lymphography and as 26.4  16.5 mm Hg by dynamic
lymphoscintigraphy (Fig 4). The Ppump values were not
significantly different between the two groups (P .05; Fig
5). These values were significantly correlated with values
taken using dynamic lymphoscintigraphy (r2  0.54, P 
.01). However, Bland-Altman plots showed that two SDs
of the mean were approximately 20 mm Hg, suggesting a
Fig 5. A, Correlation and (B) Bland-Altman Plots descr
by indocyanine green (ICG) fluorescence lymphograp
diagram shows the mean differences (solid line), and tole
Lymphatic pumping pressure.substantial disagreement between the two methods.Comparison of lymphatic pumping in healthy vol-
unteers and patients with secondary lymphedema. ICG
fluorescence lymphography was performed while patients
were seated. Among healthy individuals, Ppump was 29.3
16.0 mm Hg; among those with lymphedema, Ppump was
13.2  14.9 mm Hg. These values were significantly dif-
ferent between the two groups (P  .01; Fig 6).
DISCUSSION
In this study, we combined the lymphoscintigraphy
cuff technique with ICG fluorescence lymphography. Un-
like previous methods, our technique enables real-time
measurement of lymphatic pressure. We found that 60 mm
Hg was enough to stop the superficial leg lymph flow in all
participants. Ideally, we would have liked to confirm the
accuracy of the ICG fluorescence lymphography values by
comparing them with readings obtained from direct can-
nulation of a pressure transducer into the superficial lym-
phatic vessel. Because this technique was determined to be
e relationship between the lymphatic pumping obtained
d dynamic lymphoscintigraphy. B, The Bland-Altman
upper and lower 1.96 SD limits (dotted lines). Ppump,
Fig 6. Comparison of lymphatic pumping in healthy legs and
lymphedematous legs while volunteers were sitting. Data are
shown as mean  SD.ibe th
hy an
ranceinvasive and unethical, we used dynamic lymphoscintigram,
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values of lymphatic pumping. Pressure readings obtained
from both techniques were highly correlated. However,
values measured with the different techniques differed by as
much as 30 mm Hg, indicating that further work will be
needed to confirm the accuracy of the new method. The
transparent cuff permits us to accurately trace and measure
the contrast agent’s transit time. In most individuals, this
took 3 minutes or less. However, we used time intervals of
5 minutes in case the frequency of the lymphatic contrac-
tion might decrease or become stagnant under the cuff
pressure.
Lymphatic pumping in healthy legs in AAA patients
was determined to be 25.2 16.7 mmHg while they were
supine and 29.3 16.0 mmHg in healthy volunteers who
were sitting. These values were slightly lower than those
reported by Olszewski et al.8 These differences might be
caused by our protocol of reducing cuff pressure in 10-mm
Hg steps over the course of the reading. This could cause
our data to be anywhere from 0 to 9 mm Hg lower than
actual pressure values or cause considerable variation
among values in each group. In the future, reducing the
cuff pressure with smaller steps would likely yield more
accurate readings. The variation might also be attributable
to the diversity of ages among our participants. One recent
study demonstrated that the pumping activity of thoracic
ducts was lower in aged rats than in younger rats; therefore,
aging might be a critical factor influencing lymphatic
pumping values.20
Nonetheless, our method has many advantages. First of
all, it is easy and safe (ICG is approved for use in hospitals
worldwide). It is also less invasive than lymphoscintigraphy
and, especially, direct cannulation of a pressure transducer.
In addition, ICG fluorescence lymphography is more eco-
nomical than lymphoscintigraphy and allows measurement
of lymphatic pumping in sitting and standing positions.
This is particularly important when investigating lymphatic
activity in swollen legs, which could be caused by an inabil-
ity of the lymphatic pumping system to overcome gravita-
tional forces. Although our technique is capable of measur-
ing lymphatic pumping in this position, the bulky gamma
camera setting used in lymphoscintigraphy requires that
patients remain supine.
On the whole, these many benefits of ICG fluorescence
lymphography suggest that it could easily become an office-
based diagnostic tool for assessing lymphatic function of
the extremities. However, the current technique can only
detect lymphatic vessels located 2 cm from the body
surface; this makes it difficult to detect deep lymph vessels,
which run in the subfascial space. Advances in fluorescence
contrast agent sensitivity, as well as improvements to imag-
ing instruments, will only serve to enhance the advantages
of the ICG fluorescence lymphography technique.21,22
In this study, we demonstrated that lymphatic pump-
ing force was reduced in legs with relatively early stages
(grade I or II) of secondary lymphedema. This could cause
lymph stasis, leading to swelling of the legs. Similar trends
have been observed in patients who acquired secondarylymphedema in their arms after undergoing axillary surgery
for breast cancer.1,2 Unfortunately, the mechanisms lead-
ing to the reductions in lymphatic pumping reported in
these patients still need to be elucidated. Most of the
lymphedema patients in our study underwent extended
lymph node dissection, which damaged lymphatic passage-
ways and might have increased lymphatic afterload. In
animal models of secondary lymphedema, extended lymph
node dissection at the inguinal region, together with radi-
ation, caused a high frequency of leg lymphedema.23 Sus-
tained lymph overload may adversely affect the pump func-
tion and overwhelm the lymphatic systems.24-26 With ICG
fluorescence lymphography, we were only able to observe
subcutaneous lymph collector vessels and precollector ves-
sels in the fibrous layer of the dermis due to the detection
depth of the infrared camera system.
In chronic lymphedema, lymph collectors and also
larger lymph vessels aremarked by two changes: hyperplasia
of the muscle fibers and ill-defined increases in fiber con-
tent. Both changes result in dilation of vessels. The in-
creased fiber content also leads to reduced contractibility of
the vessels.27
Future studies should attempt to measure lymphatic
pumping among patients who require axillary or pelvic
surgery. Through comparisons of lymphatic pumping be-
fore and after surgery, data from this research might enable
us to better predict the occurrence of lymphedema in
at-risk patients or even diagnose a grade 0 lymphedema,
which is currently difficult to diagnose. Furthermore, hith-
erto unmeasured reductions in lymphatic pumping force
may be responsible for diagnoses of “leg edema due to
unknown causes.” Studies involving ICG fluorescence lym-
phography will be able to investigate this possibility. Thus,
themethods presented in this study are clearly an important
first step towards understanding how an increased knowl-
edge of lymphatic pumping can be used in a clinical setting.
However, further studies are needed to accumulate data
that provide more detailed information on the normal
ranges of lymphatic pumping. For instance, measurements
should be taken across a larger study population so that
comparisons can be made among age groups and between
genders. It will also be interesting to measure the response
of lymphatic pumping to circadian changes.
CONCLUSIONS
This novel technique of measuring lymphatic pumping
in legs using ICG fluorescence lymphography and a trans-
parent sphygmomanometer cuff is safe and minimally inva-
sive, which allows its repeated use. By comparing lymphatic
pumping values between healthy and lymphedematous
legs, we determined that the contractile force of the lym-
phatics is reduced in the lymphedematous legs. This sug-
gests that further research with this technique could have
important clinical applications. Further, use of this tech-
nique may facilitate an improved understanding of how
lymph function may contribute to hitherto unexplained
cases of leg swelling.
JOURNAL OF VASCULAR SURGERY
October 2010952 Unno et alAUTHOR CONTRIBUTIONS
Conception and design: NU
Analysis and interpretation: NU, MN, MS, HT, NY, DS,
YM, HK
Data collection: MN, MS, HT, NY, DS, YM
Writing the article: NU
Critical revision of the article: NU
Final approval of the article: NU, MN, MS, HT, NY, DS,
YM, HK
Statistical analysis: NU
Obtained funding: Not applicable
Overall responsibility: NU
REFERENCES
1. Modi S, Stanton AWB, Svensson WE, Peters AM, Mortimer PS, Levick
JR. Human lymphatic pumping measured in healthy and lymphoede-
matous arms by lymphatic congestion lymphoscintigraphy. J Physiol
2007;583:271-85.
2. Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS. Recent
advances in breast cancer-related lymphedema of the arm: lymphatic
pump failure and predisposing factors. Lymphat Res Biol 2009;7:
29-45.
3. Gashev AA, Zawieja DC. Physiology of human lymphatic contractility:
a historical perspective. Lymphology 2001;34:124-34.
4. Kinmonth JB, Taylor GW. Spontaneous rhythmic contractility in hu-
man lymphatics. J Physiol 1956;133:3P.
5. Szegvati M, Lakos A, Szontagh F, Földi M. Spontaneous contractions
of lymphatic vessels in man. Lancet 1963;7294:1329.
6. Tilney NL, Murray JE. Chronic thoracic duct fistula: operative technic
and physiological effects in man. Ann Surg 1968;167:1-8.
7. Olszewski WL, Engeset A. Lymphatic contractions. N Engl J Med
1979;300:316.
8. Olszewski WL, Engeset A. Intrinsic contractility of prenodal lymph
vessels and lymph flow in human leg. Am J Physiol Heart Circ Physiol
1980;239:H775-83.
9. Stranden E, Kramer K. Lymphatic and transcapillary forces in patients
with edema following operation for lower limb atherosclerosis. Lym-
phology 1982;15:148-55.
10. Sjoberg T, Norgren L, Steen S. Contractility of human leg lymphatics
during exsecise before and after indomethacin. Lymphology 1989;22:
186-93.
11. Howarth DM, Southee AE, Whyte IM. Lymphatic flow rates and
first-aid in simulated peripheral snake or spider envenomation. Med J
Aust 1994;161:695-700.12. Gloviczki P, Calcagno D, Schirger A, Pairolero PC, Cherry KJ, Hallett
JW, et al. Noninvasive evaluation of the swollen extremity: experienceswith 190 lymphoscintigraphic examinations. J Vasc Surg 1989;9:
683-90.
13. Williams WH, Witte CL, Witte MH, McNeill GC. Radionuclide lym-
phangioscintigraphy in the evaluation of peripheral lymphedema. Clin
Nucl Med 2000;25:451-64.
14. Tiwari A, Myint F, Hamilton G. Management of lower limb lymphoe-
dema in the United Kingdom. Eur J Vasc Endovasc Surg 2006;31:
311-5.
15. Unno N, Inuzuka K, Suzuki M, Yamamoto N, Sagara D, NishiyamaM,
et al. Preliminary experience with a novel fluorescence lymphography
using indocyanine green in patients with secondary lymphedema. J Vasc
Surg 2007;45:1016-21.
16. Unno N, NishiyamaM, Suzuki M, Yamamoto N, Inuzuka K, Sagara D,
et al. Quantitative lymph imaging for assessment of lymph function
using indocyanine green fluorescence lymphography. Eur J Vasc Endo-
vasc Surg 2008;36:230-6.
17. Suzuki M, Unno N, Yamamoto N, Nishiyama M, Sagara D, Tanaka H,
et al. Impaired lymphatic function recovered after great saphenous vein
stripping in patients with varicose vein: venodynamic and lymphody-
namic results. J Vasc Surg 2009;50:1085-91.
18. Riva-Rossi S. Un nuovo sfigmomanometro. Gazz Medi di Torino
1896;47.
19. Lee BB, Bergan JJ. New clinical and laboratory staging systems to
improve management of chronic lymphedema. Lymphology 2005;38:
122-9.
20. Gasheva OY, Knippa K, Nepiushchikh ZV, Muthuchamy M, Gashev
AA. Age-related alterations of active pumping mechanisms in rat tho-
racic duct. Microcirculation 2007;14:827-39.
21. Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM.
Lymphatic imaging in humans with near-infrared fluorescence. Curr
Opin Biotechnol 2009;20:74-82.
22. Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketok-
oun R, et al. The FLARE intraoperative near-infrared fluorescence
imaging system: a first-in-human clinical trial in breast cancer sentinel
lymph node mapping. Ann Surg Oncol 2009;16:2943-52.
23. Lee-Donaldson L, Witte MH, Bernas M, Witte CL, Way D, Stea B.
Refinement of a rodent model of peripheral lymphedema. Lymphology
1999;32:111-7.
24. McHale NG. The lymphatic circulation. Irish J Med Sci 1992;161:
483-6.
25. Mortimer PS. Implication of the lymphatic system in CVI-associated
edema. Angiology 2000;51:3-8.
26. Gashev AA. Lymphatic vessels: pressure- and flow- dependent regula-
tory reactions. Ann NY Acad Sci 2008;1131:100-9.
27. Kaiserling E. Morphological changes in lymphedema and tumors. In:
Földi M, editor. Földi’s textbook of lymphology. 2nd ed. Berlin:
Elsevier GmbH; 2006. p. 322-90.Submitted Feb 6, 2010; accepted Apr 23, 2010.
